Neoadjuvant Strategy Improves Survival in Pancreatic Cancer Resection
Researchers find that total neoadjuvant therapy has a significant impact on survival for patients with borderline resectable or locally advanced PDAC.
Diagnosis & Disease Information
Erlotinib doesn’t hurt but doesn’t help standard head-and-neck therapy
Adding erlotinib did not increase treatment toxicity in squamous cell carcinoma of the head and neck, but it also did not improve survival.
Combining chemotherapy and radiation improves survival for some with rare brain cancer
Long-term follow-up results from two clinical trials have confirmed substantially longer survival for certain patients with anaplastic oligodendrogliomas if they are treated with a combination of chemotherapy and radiation therapy instead of radiation alone.
“Inoperable” pancreatic cancer may be treatable after all
Oncologists at M.D. Anderson Cancer Center found the key to screening for pancreatic cancer lies in the interpretation of preoperative CT scans.
FDA Update – July/August 2012
News about pertuzumab injection (Perjeta); ondansetron (Zofran); carfilzomib (Kyprolis); Therascreen KRAS RGQ PCR Kit; Prostate Health Index (phi); and Prepopik
Chemoradiotherapy prolongs life for older patients with lung cancer
Survival improved for elderly patients with non-small cell lung cancer who had combined chemotherapy and radiotherapy rather than radiotherapy alone.
Fewer cycles of higher-dose chemotherapy best in advanced Hodgkin lymphoma
Six cycles of higher-dose chemotherapy, not the standard eight cycles or a lower-dose variant, should be the treatment of choice for advanced Hodgkin.
No link between BMI and surgical outcome in esophageal cancer
BMI appears to have no bearing on surgical complications or survival after esophagectomy following neoadjuvant chemoradiotherapy for adenocarcinoma.
Membrane temperature offers clue to oral mucositis risk in head and neck cancer
Thermal imaging can detect early changes in the temperature of mucosal surfaces that may signal mucositis in persons with head and neck cancer who are receiving chemoradiotherapy.
- Loading...
Loading...
Loading... 
Loading...